Empagliflozin
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Diabetes & Endocrine treatment.
🧴 Clinical Application
Take orally once daily in the morning with water, with or without food. Drink plenty of water throughout the day.
⚠️ Side Effects
Common: Genital mycotic infections, urinary frequency, dysuria, volume depletion, thirst. Rare/Severe: Euglycemic diabetic ketoacidosis (DKA), Fournier's gangrene, pyelonephritis, and severe hypotension.
🛡️ Safety Warnings
Hold at least 3 days prior to scheduled major surgery. Educate patients on euglycemic DKA symptoms. Ensure adequate daily fluid intake to prevent postural hypotension.
Jan Aushadhi Products containing Empagliflozin
Found 4 generic formulation(s) containing this active ingredient.
Empagliflozin Tablets 10 mg
Empagliflozin (10 mg, 25 mg) is a highly selective SGLT2 inhibitor on the WHO Model List of Essential Medicines with landmark proven cardiovascular and renal mortality benefits. It selectively inhibits SGLT2 in the renal proximal convoluted tubules, promoting glycosuria and natriuresis, improving systemic hemodynamics, and reducing cardiac ventricular wall stress. Indicated for type 2 diabetes mellitus, reduction of cardiovascular death in adults with T2D and established CVD, heart failure (across the entire spectrum of LVEF), and chronic kidney disease.
Empagliflozin Tablets 25 mg
Empagliflozin (10 mg, 25 mg) is a highly selective SGLT2 inhibitor on the WHO Model List of Essential Medicines with landmark proven cardiovascular and renal mortality benefits. It selectively inhibits SGLT2 in the renal proximal convoluted tubules, promoting glycosuria and natriuresis, improving systemic hemodynamics, and reducing cardiac ventricular wall stress. Indicated for type 2 diabetes mellitus, reduction of cardiovascular death in adults with T2D and established CVD, heart failure (across the entire spectrum of LVEF), and chronic kidney disease.
Empagliflozin 10mg + Linagliptin 5mg Tablets
Linagliptin (5 mg) is a xanthine-based dipeptidyl peptidase-4 (DPP-4) inhibitor on the WHO Model List of Essential Medicines. It binds tightly and pseudo-irreversibly to DPP-4 with 8-fold higher potency than other gliptins. Unlike other DPP-4 inhibitors, it is excreted predominantly unchanged via the enterohepatic bile system (95%) with less than 5% renal excretion. Consequently, it requires NO dose adjustments in patients with any degree of renal impairment or hepatic dysfunction, making it the DPP-4 inhibitor of choice in chronic kidney disease. Indicated for type 2 diabetes mellitus.
Empagliflozin 25mg + Linagliptin 5mg Tablets
Linagliptin (5 mg) is a xanthine-based dipeptidyl peptidase-4 (DPP-4) inhibitor on the WHO Model List of Essential Medicines. It binds tightly and pseudo-irreversibly to DPP-4 with 8-fold higher potency than other gliptins. Unlike other DPP-4 inhibitors, it is excreted predominantly unchanged via the enterohepatic bile system (95%) with less than 5% renal excretion. Consequently, it requires NO dose adjustments in patients with any degree of renal impairment or hepatic dysfunction, making it the DPP-4 inhibitor of choice in chronic kidney disease. Indicated for type 2 diabetes mellitus.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Empagliflozin.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Empagliflozin Tablets 10 mg | 10's | ₹37.50 | JARDIANCE, GIBTULIO, EMPANORM, EMPAGREAT, COSPIAQ | ₹147.08 | 75% Save |
| Empagliflozin Tablets 25 mg | 10's | ₹61.88 | GIBTULIO, JARDIANCE, EMPANEO, COSPIAQ, EMPAONE | ₹170.43 | 64% Save |
| Empagliflozin 10mg + Linagliptin 5mg Tablets | 10's | Under Process | N/A | N/A | N/A |
| Empagliflozin 25mg + Linagliptin 5mg Tablets | 10's | Under Process | N/A | N/A | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Empagliflozin generics.